Home > Financial Ratios > ALEMBIC

ALEMBIC
Core EBITDA Growth

    Back to All Ratios
ALEMBIC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

ALEMBIC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 51.036.731.44383.10-77.92

What is the latest Core EBITDA Growth ratio of ALEMBIC ?

The latest Core EBITDA Growth ratio of ALEMBIC is 51.03 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202551.03
Mar20246.73
Mar20231.44
Mar2022383.10
Mar2021-77.92

How is Core EBITDA Growth of ALEMBIC Trending?

Years Core EBITDA Growth % Change
Mar2025 51.03
658.25
Mar2024 6.73
367.36
Mar2023 1.44
-99.62
Mar2022 383.1
Positive
Mar2021 -77.92 -

Other Financial Ratios of ALEMBIC


Compare Core EBITDA Growth ratio of peers of ALEMBIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC ₹1,996.6 Cr -1.9% -15.1% -22.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


ALEMBIC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC

-1.9%

-15.1%

-22.7%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses